rapid
recent
develop
establish
method
identifi
characteris
virus
associ
anim
human
diseas
methodolog
commonli
base
hybridis
pcr
techniqu
combin
advanc
sequenc
techniqu
term
next
gener
sequenc
alli
advanc
data
analysi
includ
use
comput
transcriptom
subtract
also
impact
field
viral
pathogen
discoveri
review
detail
molecular
detect
techniqu
discuss
applic
viral
discoveri
provid
overview
novel
virus
discov
problem
encount
attribut
diseas
causal
newli
identifi
viru
also
consid
given
anim
pathogen
particular
virus
consid
signific
sourc
emerg
human
infect
cleaveland
et
al
identif
optim
characteris
novel
organ
affect
domest
wild
anim
popul
central
protect
human
anim
health
recent
outbreak
human
infect
caus
influenza
viru
transmit
poultri
koopman
et
al
viru
transmit
pig
dawood
et
al
itoh
et
al
case
point
highlight
need
ongo
vigil
epidemiolog
surveil
pathogen
anim
popul
moreov
epidemiolog
studi
strongli
suggest
novel
infecti
agent
remain
discov
woolhous
et
al
may
contribut
host
cancer
autoimmun
disord
degen
diseas
human
relman
daltongriffin
kellam
similar
yettobeidentifi
virus
may
contribut
pathogenesi
similar
diseas
anim
virus
identifi
wide
rang
techniqu
tradit
method
includ
electron
microscopi
cell
cultur
inocul
studi
serolog
storch
wherea
mani
virus
known
today
first
identifi
techniqu
method
limit
instanc
mani
virus
cultiv
laboratori
characteris
molecular
method
amann
et
al
recent
year
seen
increas
use
techniqu
pathogen
discoveri
fig
one
approach
use
sequenc
inform
known
pathogen
identifi
relat
undiscov
agent
crosshybridis
exampl
includ
microarray
wang
et
al
subtract
lisitsyn
et
al
hybridisationbas
method
anoth
advanc
involv
pcr
amplif
pathogen
genom
complet
knowledg
pathogen
amplifi
convent
pcr
inform
limit
degener
pcr
pcr
method
sequenceindepend
singl
primer
amplif
degener
oligonucleotid
prime
pcr
random
pcr
roll
circl
amplif
also
capac
detect
complet
novel
pathogen
hybridis
pcrbase
method
effect
sampl
analys
first
enrich
viru
process
achiev
remov
host
contamin
nucleic
acid
end
result
hybridis
pcr
method
amplifi
product
requir
definit
identif
sequenc
advanc
sequenc
facilit
viru
discoveri
includ
arriv
next
second
gener
sequenc
gener
larg
amount
sequenc
data
technolog
advanc
also
result
develop
metagenom
cultureindepend
studi
collect
set
microbi
popul
microbiom
sampl
analys
sampl
nucleotid
sequenc
content
petrosino
et
al
differ
microorgan
constitut
microbiom
includ
bacteria
fungi
mostli
yeast
virus
exampl
microbiom
mammalian
biolog
includ
microbi
popul
inhabit
human
intestin
mucos
surfac
health
diseas
date
studi
viral
microbiom
virom
appli
rang
biolog
environment
sampl
includ
human
breitbart
et
al
zhang
et
al
finkbein
et
al
equin
cann
et
al
intestin
content
bat
guano
sea
water
breitbart
et
al
angli
et
al
williamson
et
al
marin
sediment
breitbart
et
al
fresh
water
breitbart
et
al
djikeng
et
al
hot
spring
schoenfeld
et
al
soil
fierer
et
al
plant
coetze
et
al
earli
result
larg
initi
describ
human
microbiom
associ
health
diseas
recent
publish
nelson
et
al
find
togeth
studi
like
lead
discoveri
wealth
previous
unknown
virus
review
describ
current
molecular
techniqu
avail
detect
virus
infect
anim
human
begin
discuss
hybridis
pcrbase
method
describ
advanc
facilit
detect
complet
novel
virus
advanc
sequenc
methodolog
data
analysi
transcriptom
subtract
also
apprais
review
conclud
assess
problem
encount
attempt
attribut
diseas
causal
newli
discov
viru
microarray
consist
highdens
oligonucleotid
probe
segment
dna
immobilis
solid
surfac
complementari
sequenc
label
fluoresc
nucleotid
test
sampl
hybridis
probe
microarray
result
hybridis
detect
quantifi
fluorescencebas
detect
thu
rel
abund
nucleic
acid
sequenc
sampl
determin
clewley
two
type
microarray
techniqu
commonli
use
viru
identif
first
use
short
oligonucleotid
probe
sensit
singlebas
mismatch
detect
identifi
known
subtyp
known
virus
techniqu
use
discrimin
human
herp
virus
exampl
foldespapp
et
al
second
type
microarray
method
employ
long
oligonucleotid
probe
bp
allow
sequenc
mismatch
wang
et
al
microarray
applic
use
discoveri
novel
anim
virus
coronaviru
beluga
whale
mihindukulasuriya
et
al
bornaviru
caus
proventricular
dilat
diseas
wild
psittacin
bird
kistler
et
al
enteroviru
associ
tongu
eros
bottlenos
dolphin
nollen
et
al
human
medicin
use
characteris
sarscov
wang
et
al
identifi
novel
coronavirus
rhinovirus
asthmat
kistler
et
al
gammaretroviru
prostat
tissu
urisman
et
al
cardiovirus
gastrointestin
tract
microarray
technolog
power
tool
screen
larg
number
potenti
pathogen
simultan
wang
et
al
palacio
et
al
xiaop
et
al
method
limit
howev
process
interpret
hybridis
signal
trivial
one
often
involv
empir
characteris
signal
produc
known
virus
develop
specialis
softwar
urisman
et
al
furthermor
microarray
techniqu
utilis
probe
finit
specif
particular
pathogen
small
group
pathogen
novel
highli
diverg
strain
virus
difficult
detect
nonspecif
bind
test
materi
hybridis
probe
also
result
loss
test
sensit
despit
limit
microarray
proven
extrem
effect
novel
pathogen
discoveri
form
hybridis
identifi
sequenc
differ
two
relat
sampl
base
principl
remov
common
nucleic
acid
sequenc
two
sampl
leav
differ
sequenc
intact
process
appli
pair
nucleic
acid
sourc
treat
vs
untreat
diseas
vs
undiseas
tissu
sampl
obtain
prior
experiment
infect
muerhoff
et
al
subtract
hybridis
use
two
nucleic
acid
sourc
term
tester
driver
tester
contain
pathogen
sequenc
ambros
clewley
dna
tester
driver
digest
restrict
enzym
adaptor
ligat
dna
fragment
tester
sampl
two
dna
popul
mix
denatur
anneal
form
three
type
molecul
testertest
hybrid
testerdriv
driverdriv
testertest
molecul
enrich
pathogen
preferenti
exponenti
amplifi
primer
specif
adaptor
present
dna
strand
testerdriv
molecul
contain
adaptor
one
dna
strand
undergo
linear
amplif
remov
enzymat
digest
driverdriv
molecul
adaptor
amplifi
suffici
enrich
way
tester
sampl
sequenc
pathogen
identifi
exampl
subtract
hybridis
method
represent
differ
analysi
rda
lisitsyn
et
al
despit
impress
perform
model
system
rda
limit
success
discoveri
novel
virus
larg
due
requir
two
highli
match
nucleic
acid
sourc
restrict
enzym
digest
also
lead
increas
dna
complex
risk
ineffici
subtract
hybridis
particular
problem
sampl
contain
larg
amount
host
dna
serum
plasma
despit
limit
rda
use
identifi
agent
caus
kaposi
sarcoma
human
chang
et
al
torqu
teno
transfusiontransmit
viru
ttv
nishizawa
et
al
hepat
gbva
gbvb
virus
simon
et
al
convent
pcr
frequent
use
identifi
exclud
presenc
viru
sampl
given
method
reli
anneal
specif
primer
complementari
pathogen
genom
sequenc
interest
unsuit
detect
novel
virus
mark
sequenc
differ
primer
prior
knowledg
viral
sequenc
therefor
prerequisit
altern
pcr
method
degener
pcr
use
primer
design
anneal
highlyconserv
sequenc
region
share
relat
virus
region
almost
never
complet
conserv
primer
gener
includ
degeneraci
permit
bind
common
known
variant
conserv
sequenc
rose
et
al
overal
aim
achiev
balanc
cover
possibl
viral
variant
within
famili
ie
primer
high
degeneraci
creat
unwieldi
number
differ
primer
high
level
degeneraci
small
proport
primer
abl
prime
dna
synthesi
wherea
larg
proport
remain
primer
abl
anneal
sequenc
mismatch
refractori
pcr
extens
maximum
level
degeneraci
usual
fix
approxim
degeneraci
reduc
use
codon
usag
tabl
wada
et
al
intercodon
dinucleotid
frequenc
smith
et
al
degener
primer
use
detect
virus
includ
novel
virus
exist
suffici
homolog
viru
famili
primer
use
identif
pig
endogen
retroviru
perv
patienc
et
al
numer
macaqu
gammaherpesvirus
van
devant
et
al
rose
et
al
novel
alphaherpesviru
associ
death
rabbit
jin
et
al
novel
chimpanze
polyomaviru
john
et
al
novel
virus
infect
human
detect
use
techniqu
includ
hepat
g
viru
simon
et
al
hantaviru
sin
nombr
viru
nichol
et
al
coronavirus
sampath
et
al
parainfluenza
virus
corn
et
al
sequenceindepend
amplif
viral
nucleic
acid
avoid
potenti
limit
method
particularli
lack
microarray
hybridis
due
genet
diverg
known
virus
absenc
match
sampl
subtract
hybridis
pcr
amplif
use
convent
degener
primer
fail
advantag
method
abil
detect
novel
virus
highli
diverg
alreadi
known
rel
speed
simplic
use
lack
bia
identifi
particular
group
virus
delwart
sequenceindepend
amplif
techniqu
term
sequenceindepend
singl
primer
amplif
sispa
introduc
almost
two
decad
ago
identifi
viral
nucleic
acid
unknown
sequenc
present
low
amount
sispa
use
first
sequenc
noroviru
genom
human
faec
matsui
et
al
addit
astroviru
matsui
et
al
rotaviru
lambden
et
al
infect
human
origin
sispa
method
involv
endonucleas
digest
dna
follow
direct
ligat
asymmetr
adaptor
primer
end
dna
molecul
common
end
sequenc
adaptor
allow
dna
amplifi
subsequ
pcr
reaction
use
complementari
singl
primer
due
low
complex
viral
genom
enzymat
digest
produc
larg
amount
limit
number
fragment
amplif
visibl
discret
band
agaros
gel
sequenc
identifi
alland
et
al
sinc
anim
bacteri
genom
larger
complex
restrict
digest
gener
mani
differents
fragment
amplif
result
smear
agaros
gel
one
disadvantag
sequenceindepend
amplif
techniqu
contemporan
amplif
contamin
host
bacteri
nucleic
acid
enrich
method
reduc
background
genom
materi
includ
filtrat
ultracentrifug
densitygradi
ultracentrifug
enzymat
digest
nonvir
nucleic
acid
use
dnase
rnase
delwart
techniqu
take
advantag
differenti
protect
afford
viru
genom
nucleocapsid
capsid
howev
viral
nucleic
acid
protect
capsid
remov
purif
process
amplifi
potenti
assay
sensit
lost
furthermor
random
natur
amplif
reaction
mean
great
care
must
taken
maintain
pcr
integr
prevent
crosscontamin
origin
sispa
method
modifi
includ
step
detect
rna
dna
virus
enrich
viru
remov
host
genom
contamin
nucleic
acid
alland
et
al
djikeng
et
al
novel
human
anim
virus
detect
clinic
sampl
use
modifi
method
includ
parvovirus
alland
et
al
jone
et
al
coronaviru
van
der
hoek
et
al
adenoviru
jone
et
al
orthoreoviru
picornaviru
jone
et
al
porcin
pestiviru
kirkland
et
al
sequenceindepend
amplif
techniqu
term
degener
oligonucleotid
prime
pcr
doppcr
initi
develop
genom
map
studi
teleniu
et
al
recent
modifi
detect
viral
genom
materi
nanda
et
al
doppcr
use
primer
short
nucleotid
anchor
sequenc
typic
occur
everi
bp
respect
preced
nonspecif
degener
sequenc
nucleotid
random
prime
immedi
upstream
nonspecif
degener
sequenc
primer
also
contain
defin
sequenc
nucleotid
degener
sequenc
reaction
includ
mixtur
sever
thousand
differ
primer
low
stringenc
first
doppcr
amplif
cycl
least
consecut
nucleotid
end
primer
anneal
dna
sequenc
pcr
templat
subsequ
cycl
higher
stringenc
initi
pcr
product
amplifi
use
primer
popul
doppcr
follow
sequenc
product
advantag
facilit
detect
rna
dna
virus
without
priori
knowledg
infecti
agent
nanda
et
al
altern
sequenceindepend
amplif
techniqu
known
random
pcr
froussard
method
commonli
use
amplifi
label
probe
fluoresc
dye
microarray
analysi
also
use
identif
novel
virus
unlik
sispa
random
pcr
requir
adaptor
ligat
step
compar
convent
pcr
utilis
pair
complementari
forward
revers
primer
amplifi
dna
direct
random
pcr
utilis
two
differ
primer
two
separ
pcr
reaction
singl
primer
use
first
pcr
reaction
defin
sequenc
end
follow
degener
hexam
heptam
sequenc
end
second
pcr
reaction
perform
specif
primer
complementari
defin
region
first
primer
thu
enabl
amplif
product
form
first
reaction
random
pcr
use
extens
detect
dna
rna
virus
current
molecular
method
commonli
use
identifi
unknown
virus
virus
infect
anim
identifi
use
techniqu
includ
dicistroviru
associ
honeybe
coloni
collaps
disord
coxfost
et
al
seal
picornaviru
circular
dna
virus
faec
wildliv
chimpanze
blinkova
et
al
random
pcr
also
prove
success
detect
novel
virus
infect
human
includ
parvoviru
alland
et
al
coronaviru
polyomaviru
patient
respiratori
tract
diseas
alland
et
al
parechoviru
li
et
al
picornaviru
li
et
al
bocaviru
patient
diarrhoea
human
gammapapillomaviru
patient
enceph
li
et
al
sever
virus
children
acut
flaccid
paralysi
victoria
et
al
roll
circl
sequenceindepend
amplif
techniqu
make
use
properti
circular
dna
molecul
plasmid
viral
genom
replic
roll
circl
mechan
rca
mimic
natur
process
without
requir
prior
knowledg
viral
sequenc
utilis
random
hexam
primer
bind
multipl
locat
circular
dna
templat
polymeras
enzym
bacteriophag
dna
polymeras
polymeras
enzym
strong
stranddisplac
capabl
high
process
approxim
basesbind
event
proofread
activ
esteban
et
al
polymeras
enzym
come
full
circl
circular
viral
genom
displac
end
continu
extend
new
strand
multipl
time
around
dna
circl
random
primer
anneal
displac
strand
convert
doublestrand
dna
dean
et
al
use
multiplyprim
rca
unknown
circular
dna
templat
exponenti
amplifi
long
doublestrand
dna
product
cut
restrict
enzym
releas
linear
fragment
sequenc
identifi
length
circl
although
technic
demand
method
sequenceindepend
amplif
rca
approach
facilit
identif
novel
variant
bovin
papillomaviru
rector
et
al
novel
papillomavirus
florida
manate
rector
et
al
method
also
yield
full
genom
sequenc
polyomavirus
john
et
al
anelloviru
niel
et
al
circovirus
john
et
al
wasp
polydnaviru
espagn
et
al
use
combin
rca
sispa
nine
anellovirus
found
human
plasma
cat
saliva
detect
characteris
biagini
et
al
hybridis
pcr
method
gener
product
requir
definit
identif
sequenc
one
method
achiev
commonli
use
chain
termin
method
often
refer
sanger
dideoxi
sequenc
method
base
dna
polymerasedepend
synthesi
complementari
dna
strand
presenc
natur
doexynucleotid
dntp
didoexynucleotid
ddntp
serv
nonrevers
synthesi
termin
sanger
et
al
limit
techniqu
term
viru
identif
requir
clone
viral
sequenc
bacteria
prior
sequenc
although
direct
sequenc
pcr
product
also
employ
clone
perform
use
method
hostrel
bia
occur
hall
rel
limit
number
clone
sequenc
method
enrich
viru
prior
amplif
requir
recent
use
sanger
method
partial
succeed
next
gener
sequenc
technolog
circumv
need
clone
use
highli
effici
vitro
dna
amplif
morozova
marra
next
gener
sequenc
technolog
includ
pyrosequencingbas
instrument
roch
appli
scienc
genom
analys
illumina
solid
system
appli
biosystem
approach
dramat
increas
costeffect
sequenc
throughput
albeit
expens
sequenc
readlength
compar
readlength
region
bp
produc
modern
autom
sanger
instrument
readlength
approxim
bp
gener
illumina
bp
technolog
compar
short
readlength
next
gener
sequenc
technolog
howev
compens
larg
number
read
gener
typic
kilobas
sequenc
data
produc
modern
sanger
instrument
sequenc
capabl
gener
megabas
data
illumina
sequenc
technolog
produc
gigabas
sequenc
datarun
metzker
sever
differ
approach
use
analys
data
produc
sequenc
method
date
major
novel
virus
discov
use
basic
local
align
search
tool
blast
programm
compar
detect
nucleotid
sequenc
databas
reli
fact
novel
virus
homolog
known
virus
detect
distant
viral
rel
complet
new
virus
howev
problemat
instanc
proport
sequenc
deriv
anim
sampl
sequenceindepend
amplif
method
even
greater
fraction
sequenc
deriv
environment
sampl
nucleotid
amino
acid
sequenc
similar
virus
list
exist
databas
delwart
howev
use
method
virus
identifi
distantli
relat
known
virus
sever
approach
use
increas
likelihood
identifi
viru
includ
queri
translat
dna
sequenc
translat
dna
databas
evolutionari
relationship
remain
detect
longer
amino
acid
nucleotid
level
comput
gener
theoret
ancestr
sequenc
subsequ
use
sequenc
similar
search
may
also
improv
identif
highli
diverg
viral
sequenc
delwart
comput
biologist
also
develop
new
ingeni
algorithm
techniqu
analys
data
produc
next
gener
sequenc
aid
identif
novel
virus
wooley
et
al
virus
identifi
hybridis
pcr
method
previous
describ
gener
requir
initi
step
enrich
viru
amplif
step
fig
enrich
result
loss
viral
nucleic
acid
thu
reduc
test
sensit
amplif
gener
bia
toward
domin
potenti
hostderiv
sequenc
method
known
transcriptom
subtract
develop
viral
discoveri
weber
et
al
advantag
perform
without
need
enrich
amplif
fig
transcriptom
subtract
base
princip
gene
transcrib
express
produc
mrna
convert
vitro
singlestrand
dna
product
complementari
dna
cdna
sequenc
cdna
rather
genom
dna
therefor
allow
transcrib
portion
genom
analys
view
larg
number
transcript
present
sequenc
usual
perform
use
next
gener
technolog
techniqu
work
assumpt
sampl
infect
viru
would
contain
host
viral
transcript
host
transcript
sequenc
align
subtract
public
databas
case
human
sampl
includ
refer
sequenc
human
refseq
rna
mitochondri
assembl
chromosom
sequenc
nation
centr
biotechnolog
inform
ncbi
databas
align
subtract
human
sequenc
databas
nonmatch
virusenrich
sequenc
remain
studi
complet
sequenc
sever
anim
genom
transcriptom
subtract
techniqu
applic
varieti
speci
possibl
exist
use
public
databas
subtract
uninfect
control
materi
transcriptom
subtract
method
use
identifi
previous
unknown
polyomaviru
human
merkel
cell
carcinoma
feng
et
al
identifi
uncharacteris
arenaviru
associ
three
transplantrel
death
palacio
et
al
techniqu
advantag
abl
identifi
small
amount
viru
case
polyomaviru
detail
viral
transcriptscel
present
given
cell
contain
approxim
million
host
transcript
small
proport
cellular
rna
virusderiv
provid
everi
cell
infect
even
low
level
million
sequenc
read
give
probabl
detect
least
one
viral
sequenc
fig
larg
number
read
readili
obtain
use
next
gener
technolog
illumina
platform
howev
techniqu
limit
cell
infect
sequenc
methodolog
use
produc
sequenc
read
probabl
detect
viral
sequenc
decreas
approxim
respect
mani
newli
identifi
virus
infect
anim
human
initi
found
patient
particular
clinic
sign
symptom
causal
associ
particular
diseas
detect
virus
context
may
mere
reflect
presenc
viru
sampl
abil
viru
replic
within
particular
diseas
environ
rather
viru
directli
caus
diseas
exampl
although
sever
infecti
agent
found
sampl
human
patient
multipl
sclerosi
johnson
et
al
challon
et
al
perron
et
al
thacker
et
al
causal
role
pathogenesi
never
attribut
munz
et
al
similarli
herp
simplex
viru
strongli
implic
caus
cervic
cancer
human
mani
year
human
papilloma
viru
dna
identifi
biopsi
durst
et
al
henlekoch
postul
well
known
set
criteria
must
fulfil
microorgan
proven
caus
diseas
abil
cultur
virus
vitro
detect
antibodi
virus
led
new
propos
demonstr
causal
river
advanc
technolog
result
new
challeng
assign
causat
sequencebas
approach
viru
identif
led
formul
guidelin
defin
relationship
presenc
viral
sequenc
diseas
frederick
relman
guidelin
use
link
hepat
c
viru
hcv
nona
nonb
hepat
kuo
et
al
human
kaposi
sarcoma
moor
chang
noel
et
al
often
ignor
race
assign
signific
viru
discoveri
infecti
diseas
research
balanc
must
struck
prompt
identif
highli
signific
new
human
pathogen
pandem
swine
influenza
dawood
et
al
clearli
defin
tenuou
connect
xenotrop
murin
leukaemia
virusrel
viru
xmrv
chronic
fatigu
syndrom
lombardi
et
al
epidemiolog
immunolog
sequencebas
criteria
support
propos
link
infecti
organ
diseas
studi
establish
causal
must
also
involv
appreci
full
rang
genet
divers
viral
speci
well
establish
distinct
viral
genotyp
even
minor
genet
variat
result
larg
chang
viral
pathogen
viral
identif
everevolv
disciplin
new
technolog
like
signific
impact
come
decad
develop
hybridis
pcrbase
method
increas
avail
next
gener
sequenc
improv
transcriptom
subtract
method
continu
expans
viral
anim
genom
databas
improv
bioinformat
tool
facilit
acceler
identif
process
neither
author
paper
financi
person
relationship
peopl
organis
could
inappropri
influenc
bia
content
paper
